vs
Side-by-side financial comparison of OXFORD INDUSTRIES INC (OXM) and P3 Health Partners Inc. (PIII). Click either name above to swap in a different company.
P3 Health Partners Inc. is the larger business by last-quarter revenue ($384.8M vs $307.3M, roughly 1.3× OXFORD INDUSTRIES INC). P3 Health Partners Inc. runs the higher net margin — -19.6% vs -20.7%, a 1.1% gap on every dollar of revenue. On growth, P3 Health Partners Inc. posted the faster year-over-year revenue change (3.8% vs -0.2%). Over the past eight quarters, P3 Health Partners Inc.'s revenue compounded faster (-0.5% CAGR vs -3.0%).
Oxford Industries, Inc. is a publicly traded clothing company in the United States that specializes in high-end clothing and apparel. The company carries many major labels, including Tommy Bahama, Lilly Pulitzer, Johnny Was and Southern Tide.
P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.
OXM vs PIII — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $307.3M | $384.8M |
| Net Profit | $-63.7M | $-75.5M |
| Gross Margin | 60.3% | — |
| Operating Margin | -27.7% | -40.0% |
| Net Margin | -20.7% | -19.6% |
| Revenue YoY | -0.2% | 3.8% |
| Net Profit YoY | -1517.6% | -28.8% |
| EPS (diluted) | $-4.28 | $-23.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $307.3M | $384.8M | ||
| Q3 25 | $403.1M | $345.3M | ||
| Q2 25 | $392.9M | $355.8M | ||
| Q1 25 | — | $373.2M | ||
| Q4 24 | $308.0M | $370.7M | ||
| Q3 24 | $419.9M | $362.1M | ||
| Q2 24 | $398.2M | $379.2M | ||
| Q1 24 | $404.4M | $388.5M |
| Q4 25 | $-63.7M | $-75.5M | ||
| Q3 25 | $16.7M | $-31.6M | ||
| Q2 25 | $26.2M | $-20.4M | ||
| Q1 25 | — | $-20.5M | ||
| Q4 24 | $-3.9M | $-58.6M | ||
| Q3 24 | $40.6M | $-46.5M | ||
| Q2 24 | $38.4M | $-12.0M | ||
| Q1 24 | $-60.1M | $-18.7M |
| Q4 25 | 60.3% | — | ||
| Q3 25 | 61.4% | — | ||
| Q2 25 | 64.2% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 63.1% | — | ||
| Q3 24 | 63.1% | — | ||
| Q2 24 | 64.9% | — | ||
| Q1 24 | 60.9% | — |
| Q4 25 | -27.7% | -40.0% | ||
| Q3 25 | 6.3% | -12.8% | ||
| Q2 25 | 9.2% | -9.6% | ||
| Q1 25 | — | -10.2% | ||
| Q4 24 | -2.0% | -37.4% | ||
| Q3 24 | 12.5% | -29.5% | ||
| Q2 24 | 13.2% | -8.3% | ||
| Q1 24 | -20.1% | -11.3% |
| Q4 25 | -20.7% | -19.6% | ||
| Q3 25 | 4.1% | -9.1% | ||
| Q2 25 | 6.7% | -5.7% | ||
| Q1 25 | — | -5.5% | ||
| Q4 24 | -1.3% | -15.8% | ||
| Q3 24 | 9.7% | -12.8% | ||
| Q2 24 | 9.6% | -3.2% | ||
| Q1 24 | -14.9% | -4.8% |
| Q4 25 | $-4.28 | $-23.08 | ||
| Q3 25 | $1.12 | $-9.67 | ||
| Q2 25 | $1.70 | $-6.23 | ||
| Q1 25 | — | $-6.28 | ||
| Q4 24 | $-0.25 | $-23.13 | ||
| Q3 24 | $2.57 | $-15.70 | ||
| Q2 24 | $2.42 | $-7.37 | ||
| Q1 24 | $-3.72 | $-7.86 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.0M | $25.0M |
| Total DebtLower is stronger | — | $228.4M |
| Stockholders' EquityBook value | $528.0M | $-155.2M |
| Total Assets | $1.3B | $656.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.0M | $25.0M | ||
| Q3 25 | $6.9M | $37.7M | ||
| Q2 25 | $8.2M | $38.6M | ||
| Q1 25 | — | $40.1M | ||
| Q4 24 | $7.0M | $38.8M | ||
| Q3 24 | $18.4M | $63.0M | ||
| Q2 24 | $7.7M | $73.1M | ||
| Q1 24 | $7.6M | $27.3M |
| Q4 25 | — | $228.4M | ||
| Q3 25 | — | $252.8M | ||
| Q2 25 | — | $182.0M | ||
| Q1 25 | — | $171.1M | ||
| Q4 24 | — | $108.9M | ||
| Q3 24 | — | $133.2M | ||
| Q2 24 | — | $133.1M | ||
| Q1 24 | $29.0M | $118.1M |
| Q4 25 | $528.0M | $-155.2M | ||
| Q3 25 | $597.1M | $-18.7M | ||
| Q2 25 | $592.4M | $44.5M | ||
| Q1 25 | — | $63.3M | ||
| Q4 24 | $612.2M | $75.9M | ||
| Q3 24 | $621.6M | $120.5M | ||
| Q2 24 | $592.9M | $166.8M | ||
| Q1 24 | $560.9M | $146.6M |
| Q4 25 | $1.3B | $656.6M | ||
| Q3 25 | $1.3B | $683.6M | ||
| Q2 25 | $1.3B | $731.6M | ||
| Q1 25 | — | $783.9M | ||
| Q4 24 | $1.2B | $783.4M | ||
| Q3 24 | $1.2B | $833.3M | ||
| Q2 24 | $1.2B | $892.8M | ||
| Q1 24 | $1.1B | $855.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.09× | ||
| Q1 25 | — | 2.71× | ||
| Q4 24 | — | 1.43× | ||
| Q3 24 | — | 1.11× | ||
| Q2 24 | — | 0.80× | ||
| Q1 24 | 0.05× | 0.81× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-9.1M | $-25.7M |
| Free Cash FlowOCF − Capex | $-47.9M | — |
| FCF MarginFCF / Revenue | -15.6% | — |
| Capex IntensityCapex / Revenue | 12.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-79.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-9.1M | $-25.7M | ||
| Q3 25 | $83.5M | $-15.4M | ||
| Q2 25 | $-3.9M | $-16.6M | ||
| Q1 25 | — | $-33.5M | ||
| Q4 24 | $-18.2M | $-57.2M | ||
| Q3 24 | $88.8M | $-22.6M | ||
| Q2 24 | $32.9M | $-10.2M | ||
| Q1 24 | $74.9M | $-20.0M |
| Q4 25 | $-47.9M | — | ||
| Q3 25 | $52.3M | — | ||
| Q2 25 | $-27.4M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-56.9M | — | ||
| Q3 24 | $47.2M | — | ||
| Q2 24 | $21.0M | — | ||
| Q1 24 | $55.3M | — |
| Q4 25 | -15.6% | — | ||
| Q3 25 | 13.0% | — | ||
| Q2 25 | -7.0% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -18.5% | — | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | 5.3% | — | ||
| Q1 24 | 13.7% | — |
| Q4 25 | 12.6% | — | ||
| Q3 25 | 7.7% | — | ||
| Q2 25 | 6.0% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 12.6% | 0.0% | ||
| Q3 24 | 9.9% | 0.0% | ||
| Q2 24 | 3.0% | 0.0% | ||
| Q1 24 | 4.8% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | 5.00× | — | ||
| Q2 25 | -0.15× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.19× | — | ||
| Q2 24 | 0.86× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OXM
| Sales Channel Retail | $162.9M | 53% |
| Sales Channel Wholesale | $61.3M | 20% |
| Johnny Was | $45.4M | 15% |
| Sales Channel Food And Beverage | $29.3M | 10% |
| Other Foreign Countries | $9.0M | 3% |
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
